Construction and in vitro characterization of a molecularly cloned human immunodeficiency virus type 1 library

By Mukai T.   Kurosu T.   Kinomoto M.   Komoto S.   Shiraga M.   Auwanit W.   Ikuta K.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1181-1185

Elsevier

Access to resources Recommend Favorite

Acellular pertussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection

By de Martino M.   Podda A.   Galli L.   Sinangil F.   Mannelli F.   Rossi M.E.   Vierucci A.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1235-1238

Elsevier

Access to resources Recommend Favorite

Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine

By Chujoh Y.   Matsuo K.   Yoshizaki H.   Nakasatomi T.   Someya K.   Okamoto Y.   Naganawa S.   Haga S.   Yoshikura H.   Yamazaki A.   Yamazaki S.   Honda M.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 797-804

Elsevier

Access to resources Recommend Favorite

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

By Gorse G.J.   Patel G.B.   Mandava M.D.   Belshe R.B.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 835-849

Elsevier

Access to resources Recommend Favorite

Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3 N306 glycan

By Bolmstedt A.   Hinkula J.   Rowcliffe E.   Biller M.   Wahren B.   Olofsson S.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 397-405

Elsevier

Access to resources Recommend Favorite